MarketWatch · Top Stories· Jaimy Lee·· 14 小时前AI 评分40
Martin Shkreli 因操纵生物制药股票再遭监管机构起诉
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
AI 导读
Federal Trade Commission 与七个州指控“Pharma Bro”Martin Shkreli 操纵生物制药股票，要求法院以藐视法庭罪对其处罚。
来源：MarketWatch · Top Stories · marketwatch.com